日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli LexA repressor (lexA) CSB-YP544062ENX
CSB-EP544062ENX
CSB-BP544062ENX
CSB-MP544062ENX
CSB-EP544062ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Cobalamin synthase (cobS), partial CSB-YP544063ENX1
CSB-EP544063ENX1
CSB-BP544063ENX1
CSB-MP544063ENX1
CSB-EP544063ENX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Anaerobic nitric oxide reductase transcription regulator norR (norR) CSB-YP544064ENX
CSB-EP544064ENX
CSB-BP544064ENX
CSB-MP544064ENX
CSB-EP544064ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP544065ENX
CSB-EP544065ENX
CSB-BP544065ENX
CSB-MP544065ENX
CSB-EP544065ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 60 kDa chaperonin (groL) CSB-YP544066ENX
CSB-EP544066ENX
CSB-BP544066ENX
CSB-MP544066ENX
CSB-EP544066ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli L-ribulose-5-phosphate 4-epimerase UlaF (ulaF) CSB-YP544067ENX
CSB-EP544067ENX
CSB-BP544067ENX
CSB-MP544067ENX
CSB-EP544067ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Protein syd (syd) CSB-YP544068ENX
CSB-EP544068ENX
CSB-BP544068ENX
CSB-MP544068ENX
CSB-EP544068ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP544069ENX1
CSB-EP544069ENX1
CSB-BP544069ENX1
CSB-MP544069ENX1
CSB-EP544069ENX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Isopentenyl-diphosphate Delta-isomerase (idi) CSB-YP544070ENX
CSB-EP544070ENX
CSB-BP544070ENX
CSB-MP544070ENX
CSB-EP544070ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable cytosol aminopeptidase (pepA) CSB-YP544071ENX
CSB-EP544071ENX
CSB-BP544071ENX
CSB-MP544071ENX
CSB-EP544071ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans UPF0317 protein Mrad2831_3350 (Mrad2831_3350) CSB-YP544072MTD
CSB-EP544072MTD
CSB-BP544072MTD
CSB-MP544072MTD
CSB-EP544072MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Dihydrodipicolinate synthase (dapA) CSB-YP544073MTD
CSB-EP544073MTD
CSB-BP544073MTD
CSB-MP544073MTD
CSB-EP544073MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP544074MTD
CSB-EP544074MTD
CSB-BP544074MTD
CSB-MP544074MTD
CSB-EP544074MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP544075MTD
CSB-EP544075MTD
CSB-BP544075MTD
CSB-MP544075MTD
CSB-EP544075MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 50S ribosomal protein L32 (rpmF) CSB-YP544076MTD
CSB-EP544076MTD
CSB-BP544076MTD
CSB-MP544076MTD
CSB-EP544076MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP544077MTD
CSB-EP544077MTD
CSB-BP544077MTD
CSB-MP544077MTD
CSB-EP544077MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 30S ribosomal protein S13 (rpsM) CSB-YP544078MTD
CSB-EP544078MTD
CSB-BP544078MTD
CSB-MP544078MTD
CSB-EP544078MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 30S ribosomal protein S14 (rpsN) CSB-YP544079MTD
CSB-EP544079MTD
CSB-BP544079MTD
CSB-MP544079MTD
CSB-EP544079MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 50S ribosomal protein L23 (rplW) CSB-YP544080MTD
CSB-EP544080MTD
CSB-BP544080MTD
CSB-MP544080MTD
CSB-EP544080MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 50S ribosomal protein L16 (rplP) CSB-YP544081MTD
CSB-EP544081MTD
CSB-BP544081MTD
CSB-MP544081MTD
CSB-EP544081MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×